BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20200101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210222
DTEND;VALUE=DATE:20210226
DTSTAMP:20260515T154327
CREATED:20201021T150805Z
LAST-MODIFIED:20201021T150805Z
UID:27572-1613952000-1614297599@www.pharmajournalist.com
SUMMARY:Gene Therapy for Rare Disorders USA
DESCRIPTION:The 4th Annual Gene Therapy for Rare Disorders will focus exclusively on overcoming the late-stage commercial challenges drug developers face when delivering gene therapies to market. \nWith investment at an all-time high\, and several indications in late-stage trials gearing up for approval\, the meeting will leverage the experience from first to market pioneers\, as well as unveiling the strategies drug developers are employing to improve efficacy\, safety and commercial viability. \n \nIncorporating insights from 90+ industry-leading speakers\, this digital conference will delve into the key regulatory\, reimbursement\, clinical and manufacturing hurdles that need to be overcome to realize the commercial potential of gene therapies. \nJoin 500+ of your colleagues online to accelerate the progress of the next generation of gene therapies. \nThis is your comprehensive guide to define your commercial path forward.
URL:https://www.pharmajournalist.com/event/gene-therapy-for-rare-disorders-usa/
LOCATION:Virtual Event
ORGANIZER;CN="Hansonwade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210222
DTEND;VALUE=DATE:20210225
DTSTAMP:20260515T154327
CREATED:20201111T111102Z
LAST-MODIFIED:20201111T111102Z
UID:27878-1613952000-1614211199@www.pharmajournalist.com
SUMMARY:Operationalize: Expanded Access Programs
DESCRIPTION:Overcome the Operational Hurdles Preventing You From Bringing Treatments to Patients in Need: Say Goodbye to the Worry and Uncertainty of Setting Up and Managing an Expanded Access Program. \n \nBy bringing together the world’s leading thinkers in Expanded Access Programs\, this exclusive platform will clarify the complex issues through end-to-end Expanded Access Program Operationalization. Through open discussion\, sharing best-practice case studies\, and removing hypotheticals: this event provides an unrivalled opportunity to solve your challenges across the entire program timeline. \nOver the course of 3 interactive days\, 20 expert speakers will share their insights on program set-up\, US and EU regulatory pathways\, product supply\, data collection\, using technology to streamline processes and patient communication\, closing out programs and moving to commercialization. So\, next February\, join your peers from across the value chain to develop your own toolkit of solutions from the only case study led\, operationally–focused access programs event. \nTo know more about Operationalize: Expanded Access Programs please click here.
URL:https://www.pharmajournalist.com/event/operationalize-expanded-access-programs/
LOCATION:Virtual Event
ORGANIZER;CN="Hansonwade":MAILTO:nfo@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210222
DTEND;VALUE=DATE:20210224
DTSTAMP:20260515T154327
CREATED:20210114T085910Z
LAST-MODIFIED:20210122T141443Z
UID:28470-1613952000-1614124799@www.pharmajournalist.com
SUMMARY:Animal Health Innovation Europe
DESCRIPTION:The 6th Annual Animal Health Innovation Europe taking place on the 22-23rd February 2021 will showcase the most exciting innovations in animal health and nutrition\, connecting those businesses with financial investors and strategic corporate partners\, making it the sector’s premier investment forum in Europe. \n \nJoin us to hear investment pitches\, network with C-Suite Executives and learn from CEO-level panel discussions that address the trends and market dynamics of the animal health industry\, across all species. This year’s virtual format gives us a unique opportunity with our programming to involve a wider array of stakeholders and key participants in the value chain so we can address the full scope of how animal health impacts pet owners\, veterinarians\, and farmers today. We have advanced our networking capabilities to help you recreate the unexpected business interactions that are so valuable at our face-to-face events\, through virtual roundtable discussions\, workshop groups and interactive content delivery. \nFeaturing speakers from industry leaders such as Elanco\, Zoetis\, Phibro\, and many more\, 2021 content will cover expanded insights on: sustainability and efficiency in the protein supply chain\, the accelerated use of digital solutions in the pet sector\, how the animal health industry will continue to generate value through the Covid-19 pandemic\, and new approaches to stimulate technology adoption and enhance the productivity of European farmers. \nJoin us for the innovation showcase\, a feature of the event that is a unique opportunity for emerging companies with amazing technology to present in front of the industry’s most influential figures and investors. Split between companion and production animal sectors\, 20 start-ups\, hand-picked by the Selection Committee (who all have an extensive breadth of experience and knowledge across animal health and nutrition industries)\, introduce themselves and their innovations and achievements on the main stage. \nBook now to join us in shaping the future of animal health.
URL:https://www.pharmajournalist.com/event/animal-health-innovation-europe/
LOCATION:Virtual
ORGANIZER;CN="Kisaco Research":MAILTO:events@kisacoresearch.com
END:VEVENT
END:VCALENDAR